An event in the Oval Office on Thursday was suddenly halted when a White House guest collapsed behind President Donald Trump.
Get the latest news and live updates as the government shutdown enters Day 37, with FAA cuts to flights and energy bill assistance cuts looming.
U.S. President Donald Trump, Eli Lilly and Novo Nordisk unveiled a deal on Thursday to slash the prices of popular GLP-1 ...
Donald Trump has unveiled a deal to slash the price of GLP-1 weight loss drugs by two thirds. The White House’s deal with Novo Nordisk and Eli Lilly will see the prices of WeGovy and Ozempic, also ...
Investor's Business Daily on MSN
'It's Getting Ugly,' Analyst Says As Pfizer Escalates Its Gloves-Off Fight For Metsera
Metsera stock surged Thursday on reports Pfizer has matched Novo Nordisk's $10 billion bid to buy the obesity-focused biotech ...
Eli Lilly expects the U.S. Food and Drug Administration to approve its experimental oral obesity drug, orforglipron, by March ...
Michael Landsberg, chief investment officer at Landsberg Bennett Private Wealth Management, explained why shares of Novo ...
ABP News on MSN
Trump Strikes Landmark Deal To Slash Obesity Drug Prices, A U-Turn That Could Upend Global Pharma, Including India
In a move reverberating across global healthcare and financial markets, Donald Trump has announced a deal to cap insulin ...
The Supreme Court ruled Thursday that the Trump administration can order US passports indicate the holders’ sex at birth and ...
U.S. Health Secretary Robert F. Kennedy Jr. says the new guidelines will change the food culture in this country.
The Pfizer and Novo Nordisk battle for obesity drug developer Metsera intensified on Thursday after a fresh round of ...
U.S. President Donald Trump, Eli Lilly and Novo Nordisk unveiled a deal on Thursday to slash the prices of popular GLP-1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback